Furthermore, p16INK4A alterations are observed in head and neck38, pancreatic39, and colorectal cancer40 in precancerous lesions to early stages of the cancer, and the frequency of the alteration increases with the stage and invasiveness of the malignancy37. The gene discussed is CDKN2A; the disease is cancer.